Its truly a no-downtime procedure
According to the drug label, Wegovy is contraindicated (should not be used) in the following populations: Individuals with a known sensitivity to semaglutide or other ingredients in Wegovy Individuals with a personal or family medical history of medullary thyroid cancer (MTC) Individuals with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Wegovy is also not approved for use in pediatric patients under 12 years old or pregnant people
Exploratory outcomes included changes in waist circumference, systolic-type blood pressure, and NT-proBNP levels
"Most of us hadn't slept much
Step 1: Check your current baseline
Eric Ravussin, LSU Boyd Professor and one of the study's lead researchers, emphasized the potential implications of these findings, "Our research indicates that tirzepatide not only facilitates substantial weight loss but also enhances fat oxidation, but unfortunately, did not decrease the metabolic adaptation usually seen with weight loss